您要查找的是不是:
- Does hormone replacement therapy prevent epithelial ovarian cancer? 激素替代治疗能预防卵巢上皮癌吗?
- The expression of lung resistance protein in primary epithelial ovarian cancer a nd its clinical significance. 肺耐药蛋白在上皮性卵巢癌中的表达及临床意义。
- Objective?To investigate the relation of tumor angiogenesis to prognosis in epithelial ovarian cancer (EOC). ?目的?探讨上皮性卵巢癌血管生成活性与患者预后的关系。
- It is very important for us to screen after treatment and find early any signs of epithelial ovarian cancer recurrence. 加强对卵巢癌治疗后的检测,及早发现复发的征象,是卵巢癌整个治疗过程中非常重要的一个环节。
- Objective: To determine the expression and significance of lung resistance protein (LRP) in epithelial ovarian cancer. 目的探讨上皮性卵巢癌中肺耐药蛋白(LRP)的表达及其临床意义。
- To study the treatment results and prognostic factors of advanced epithelial ovarian cancer. 探讨晚期卵巢上皮性癌的治疗及预后影响因素。
- Objective:To explore the characteristic of circulating DNA in primary epithelial ovarian cancer(EOC) and its association with the expression of gene in tumor tissues. 探讨上皮性卵巢癌循环DNA含量的特点及其与肿瘤组织基因表达的相关性。
- Objectives: To investigate the feasibility of neoadjuvant chemotherapy (NAC) applied on patients with unresectable epithelial ovarian cancer (EOC). 目的:探讨对于首次手术难以达到满意肿瘤细胞减灭术的上皮性卵巢癌患者,采用新辅助化疗(neoadjuvant chemotherapy,NAC)治疗的可行性。
- Malignant ovarian neoplasm is a common carcinoma in female genital tract, and its prominent type is epithelial ovarian cancer (EOC). 卵巢恶性肿瘤是女性生殖道常见的恶性肿瘤,其中绝大部分为上皮性卵巢癌(Epithelial Ovarian Cancer,简称EOC)。
- DNA content and SPF are independent prognostic factors of epithelial ovarian cancer,correlating with more aggressive biologic behavior. DNA倍体、SPF值与卵巢上皮癌的恶性生物学行为有关 ,可作为卵巢上皮癌的一个重要的预后指标。
- To investigate the efficacy and toxicity of oxaliplatin-based chemotherapy in the treatment of epithelial ovarian cancer (EOC) . 目的 探讨草酸铂为主的化疗对上皮性卵巢癌的疗效及毒副作用。
- The median IRs of VBP and VAP to specific histology of epithelial ovarian cancer(EOC) were 77.3% and 71.0% , respectively. VBP、 VAP方案对上皮性卵巢癌的中位抑制率分别为 77.;3%25和 71
- Objective To investigate the significance of Osteopontin (OPN) as a tumor marker combined with CA125 in diagnosis of epithelial ovarian cancer. 目的探讨骨桥蛋白(OPN)联合癌抗原125(CA125)检测对上皮性卵巢癌的诊断价值。
- The standard treatment of epithelial ovarian cancer (EOC) includes maximally debulking surgery followed by adjuvant chemotherapy. 对于上皮性卵巢癌的标准治疗方式为尽可能最大范围的减积手术,再追加辅助性化学治疗。
- Purpose To determine the plasticity of human epithelial ovarian cancer cell SKOV3 and formation of vasculogenic mimicry in vivo. 摘要目的检测人上皮性卵巢癌细胞株SKOV3移植裸鼠腹腔成瘤后血管生成拟态的形成和分子塑形的改变。
- Conclusion: The expression of EGFR and LRP are related to angiogenesis and chemotherapy resistance in epithelial ovarian cancer. 该两指标有助于预测化疗耐药和判断患者预后。
- To observe the protective effects of follicle stimulating hormone(FSH)on human epithelial ovarian cancer cell apoptosis induced by cisplatin(DDP). 目的探讨促卵泡激素(FSH)对顺铂诱导卵巢癌细胞凋亡的保护作用。
- The combination of COC 166-9 ,183E and 183F is of high practical value for diagnosing epithelial ovarian cancer and differentiating benign from malignant ovarian tumors. 单抗COC166-9、183E、183F1联合检测对卵巢上皮癌尤其是卵巢良恶性肿瘤更具鉴别诊断意义。
- BackgroundAbout 90% of malignant ovarian neoplasm is epithelial ovarian cancer (EOC), and about 75% of EOC cases are recognized in advanced stages. We all know the basic way of therapy in EOC is primary cytoreduction and chemotherapy after surgery. 90%25以上的卵巢恶性肿瘤为上皮性卵巢癌(epithelial ovarian cancer, EOC),75%25左右患者初次诊断时为进展期,而对进展期EOC初次手术后辅以化疗的标准治疗方式已获得共识。
- Methods:The expressions of WT1 and VEGF-C proteins in 50 cases of epithelial ovarian cancer (EOC), 10 cases of benign epithelial tumor (BET), 10 cases of normal ovarian (NO) were examined by immunohistochemical streptavidin/peroxidase method. 方法采用免疫组织化学SP法检测50例卵巢上皮性癌、10例卵巢良性肿瘤和10例正常卵巢石蜡标本中WT1、VEGF-C的表达情况。